Capricor Therapeutics, Inc.
Support and Resistance Levels
Past performance
News About CAPR
All events for CAPR
All deals for CAPR
Financial Ratios
Financial Statements
CAPR vs Sector & Peers
About Capricor Therapeutics, Inc.
Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA. Website capricor.com
Headquarters San Diego, CA, US